NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its assets plus borrowings for investment purposes in foreign equity securities that have records of paying dividends.
In addition, the fund will invest in a diversified portfolio of 25 to 50 securities typically spread across many economic sectors.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ABBNY | ABB Ltd | Industrials | Electrical Equipment & Parts | 4.79% |
| SMFG | Sumitomo Mitsui Financial Group Inc | Financial Services | Banks - Diversified | 4.65% |
| BCS | Barclays PLC ADR | Financial Services | Banks - Diversified | 4.61% |
| MUFG | Mitsubishi UFJ Financial Group Inc ADR | Financial Services | Banks - Diversified | 4.61% |
| BBVA | Banco Bilbao Viscaya Argentaria SA ADR | Financial Services | Banks - Diversified | 3.78% |
| ERIC | Telefonaktiebolaget LM Ericsson B ADR | Technology | Communication Equipment | 3.62% |
| ENB | Enbridge Inc | Energy | Oil & Gas Midstream | 3.45% |
| ORANY | Orange S.A. | Communication Services | Telecom Services | 3.39% |
| ORAN | Orange SA ADR | Communication Services | Telecom Services | 3.30% |
| BNPQY | BNP Paribas SA ADR | Financial Services | Banks - Regional | 3.28% |
| VOD | Vodafone Group PLC ADR | Communication Services | Telecom Services | 3.27% |
| AZN_old | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.25% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.22% |
| ENLAY | ENEL Societa per Azioni | Utilities | Utilities - Diversified | 3.12% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.01% |
| ALIZY | Allianz SE ADR | Financial Services | Insurance - Diversified | 2.94% |
| NVS | Novartis AG ADR | Healthcare | Drug Manufacturers - General | 2.87% |
| BTI | British American Tobacco p.l.c. | Consumer Defensive | Tobacco | 2.80% |
| RIO | Rio Tinto ADR | Basic Materials | Other Industrial Metals & Mining | 2.76% |
| IX | Orix Corp Ads | Financial Services | Financial Conglomerates | 2.70% |